Cell culture of hepatitis A virus

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4352351, 435237, A61K 3912, C12N 700, C12N 708

Patent

active

055143768

ABSTRACT:
Hepatitis A virus is attenuated in virulence by in vitro passage in susceptible cell cultures, without prior passage in a subhuman primate. This process results in a live, attenuated hepatitis A virus vaccine suitable for human disease prevention.

REFERENCES:
patent: 3105011 (1963-09-01), McLean et al.
patent: 3354038 (1967-11-01), Bass et al.
patent: 3432391 (1969-03-01), Hays et al.
patent: 3470294 (1969-09-01), Drager et al.
patent: 3520972 (1970-07-01), Smith et al.
patent: 3871954 (1975-03-01), Zuckerman
patent: 3935066 (1976-01-01), Apostolov
patent: 4029764 (1977-06-01), Provost et al.
patent: 4031203 (1977-06-01), Provost et al.
patent: 4053582 (1977-10-01), Stickl
patent: 4058598 (1977-11-01), Stern et al.
patent: 4164566 (1979-08-01), Provost et al.
patent: 4506016 (1985-03-01), Flehmig
patent: 4532215 (1985-07-01), Daemer et al.
patent: 4614793 (1986-09-01), Hughes et al.
patent: 4783407 (1988-11-01), Provost et al.
patent: 4844228 (1990-01-01), Purcell et al.
patent: 5021348 (1991-06-01), Giesa et al.
Siegl, "Replication of Hepatitis A Virus and Processing of Proteins," Vaccine 10 Suppl 1, S32-S34 (1992).
Emerson et al., "Molecular Basis of Virulence and Growth . . . , " Vaccine 10, Suppl 1, S36-S39 (1992).
Lemon et al., "Genetic, Antigenic and Biological Differences Between Strains . . . , " Vaccine 10, Suppl 1, S40-S44 (1992).
Houdt, "Possible Approaches to Develop Vaccines Against Hepatitis A, " Vaccine 10, Suppl 1, S48-S52 (1992).
Tedeschi et al., "Partial Characterization of Hepatitis A . . . , " J. Med Virol. 39:16-22 (1993).
Peetermans, "Production, Quality Control and Characterization . . . , " Vaccine 10, suppl 1, S99-S101 (1992).
Just et al., "Reactogenicity and Immunogenicity of Inactivated . . . , " Vaccine 10, Suppl 1, S110-S113.
Sjogren, "Clinical and Laboratory Observations . . . , " Vaccine 10, Suppl 1, S135-S137 (1992).
"Hepatitis A Vaccine: Development, Safety & Immunogencity," Vaccine 10, Suppl 1, S146-S147 (1992).
Frosner et al., "Propagation of Human Hepatitis A Virus in a Hepatoma Cell Line," Infection 7:303--305 (1979).
Siegl et al., "Propagation and Assay of Hepatitis A Virus in Vitro," J. Virol Meth. 9:53-67 (1984).
Melnick et al., "Properties and Classification of Hepatitis A Virus," Vaccine 10: Suppl 1 S24-S26 (1992).
Balayan, "Natural Hosts of Hepatitis A Virus, " Vaccine 10: Suppl 1, S27-31 (1992).
Provost et al., "An Inactivated Hepatitis A Viral Vaccine . . . ," J. Med. Virol. 19:23-31 (1986).
Jansen et al., "Complete Nucleotide Sequence of A Cell Culture . . . , " Virology 163:299-307 (1988).
Cohen et al., "Complete Nucleotide Sequence of Wild-Type Hepatitis A Virus . . . , " J. Virol 61:50-59 (1987).
Cohen et al., "Complete Nucleotide Sequence . . . " Proc. Natl. Acad Sci 84:2497-2501 (1987).
Ross et al., "Nucleotide Sequence of High-Passage . . . , " J. Gen. Virol 70: 2805-2810 (1989).
Rightsel et al. Science, 124, pp. 226-228 (1956).
O'Malley et al. Proc. Soc. Exp. Biol. Med., 108, pp. 200-205 (1961).
Liebhaber et al. J. Exp. Med., 122, p. 1135, (1965).
O'Malley, et al., Proc. Nat. Acad. Sci., 56, p. 895 (1965).
Mirkovic et al., Proc. Soc. Exp. Biol. Med., 138, p. 626, (1971).
Advances in Viral Hepatitis, W.H.O. Tech. report, Series No. 602, (1977).
Dienstag et al., Intervirl., 6, p. 319, (1976).
Provost et al., Pro. Soc. Exp. Bio. & Med., 160, p. 213 (1979).
Provost et al., Biol. Abstract, 68, ref. No. 12885.
Feinstone et al., J. of Vir., 13, No. 6, pp. 1412-1414 (1974).
Feinstone et al., Science, 182, pp. 1026-1028 (1973).
Frosner et al., Infection, 7, 303-305 (1979).
Zuckerman, Nature, 279, p. 579 (1979).
Purcell et al. Am. J. Med. Sci. 270, 61-71 (1975).
McCollum, J. of Med. Virology 8: 1-29 (1981).
Flehming et al. Med. Micro. Immunol. 170: 83-89 (1981).
Ed. Gerety, R. J. Hepatitis A pp. 247-261 Acad. Press (1984).
Ed. Gerety, R. J. Hepatitis A pp. 33-46 Acad. Press (1984).
Bradley, et al., Char. of Hepatitis A Virus, pp. 876-889, (1976).
Deinhardt, et al. Int. Symp. O. Viral Hep. Milon, Dev. Biol. Stand., 30, 390-404 (1975).
Almond Attn. of Poliovirus Neurovirulence, 41: 153-180 (1987).
Westrop et al. J. Of Virl. 63: 1338-1344 (1989).
Gauss-Muller et al. J. of Med. Vir. 7: 233-239 (1981).
Cann et al. Nucleic Acids Research 12: 7787-7792 (1984).
Pilipenko et al. Virology 168: 201-209 (1989).
Monica et al. J. of Virology pp. 515-525 (1986).
Kawamura et al. J. of Virology pp. 1302-1309 (1989).
Siegl et al. J. of Virology pp. 40-47 (1978).
Frosner et al. J. of Med. Vir. 1: 163-173 (1977).
Lennette, et al. eds; Diag. Proc. For Viral Rickettsial and Chlamydial Inf. 5th ed, p. 907 (1979).
Kojima et al, J. Med. Virol, 7, 273-286 (1981).
Provost et al. J. Med. Virol, 20, 165-175 (1986).
Robertson et al, J.I.D., 163, 286-292 (1991).
Provost, et al., P.S.E.B.M. 142, 1257 (1974).
Mascoli et al., P.S.E.B.M. 142, 276 (1973).
Dienstag, et al. Lancet, 705, Apr. 5, 1975.
Flehmig et al., Viral Hepatitis and Liver Disease, 87-90 (1988).
Flemig et al, Viral Hepatitis and Liver Disease, 100-105 (1988).
Flehmig et al., 3, Med. Viral 22, 7-16 (1987).
Provost, P. J. and Hilleman, M. R. Hepatitis Scientific Memoranda, Memo H-1531, early Feb. 1979.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cell culture of hepatitis A virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell culture of hepatitis A virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell culture of hepatitis A virus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1225301

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.